{"protocolSection":{"identificationModule":{"nctId":"NCT06007573","orgStudyIdInfo":{"id":"2021-zj-21"},"organization":{"fullName":"The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine","class":"OTHER"},"briefTitle":"Acupuncture Combined With Nimodipine for Prevention of Post-stroke Dementia","officialTitle":"Acupuncture Combined With Nimodipine for Prevention of Post-stroke Dementia:a Randomized Controlled Trial"},"statusModule":{"statusVerifiedDate":"2023-08","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2021-02-01","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2023-08-01","type":"ACTUAL"},"completionDateStruct":{"date":"2023-08-15","type":"ACTUAL"},"studyFirstSubmitDate":"2023-08-15","studyFirstSubmitQcDate":"2023-08-22","studyFirstPostDateStruct":{"date":"2023-08-23","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-08-22","lastUpdatePostDateStruct":{"date":"2023-08-23","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR_INVESTIGATOR","investigatorFullName":"Yuzhen Pan","investigatorTitle":"DOCTOR","investigatorAffiliation":"The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine"},"leadSponsor":{"name":"Yuzhen Pan","class":"OTHER"},"collaborators":[{"name":"Department of acupuncture and massage, Nanling Hospital of traditional Chinese Medicine, Nanling County, Wuhu City, Anhui Province","class":"UNKNOWN"}]},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"To observe the clinical efficacy of TCM acupuncture combined with western medicine nimodipine for prevention of post-stroke dementia by comparing with clinical conventional treatment methods."},"conditionsModule":{"conditions":["Post-stroke Dementia"],"keywords":["randomized controlled trial","post-stroke dementia","Acupuncture","nimodipine"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"SINGLE","whoMasked":["OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":40,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"treatment group","type":"EXPERIMENTAL","description":"On the basis of the control group treatment, the treatment group also adopted the acupuncture treatment","interventionNames":["Drug: The control group received oral nimodipine tablets"]},{"label":"control group","type":"OTHER","description":"The control group received oral nimodipine tablets","interventionNames":["Drug: The control group received oral nimodipine tablets"]}],"interventions":[{"type":"DRUG","name":"The control group received oral nimodipine tablets","description":"The control group received oral nimodipine tablets","armGroupLabels":["control group","treatment group"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Response Rate","timeFrame":"24 weeks"}],"secondaryOutcomes":[{"measure":"Hasegawa Dementia Scale","timeFrame":"24 weeks"},{"measure":"Montreal Cognitive Assessment","timeFrame":"24 weeks"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Definite ischemic stroke or hemorrhagic stroke confirmed by head CT / MRI examination\n2. Memory or cognitive and executive dysfunction. Cognitive dysfunction will be determined after the mini mental state evaluation (MMSE) score\n3. Age limited to 40-85 years, irrespective of gender\n4. Stable condition, clear consciousness, no aphasia, oral medication available\n5. No major comorbidity, no major depression\n6. Consent and signed patient informed consent\n\nExclusion Criteria:\n\n1. Had serious medical conditions, such as heart, liver, kidney, or endocrine disease\n2. Aphasia or hearing impairment\n3. Participants in other clinical trials\n4. Patients currently on medication to improve cognitive function","healthyVolunteers":false,"sex":"ALL","minimumAge":"40 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"locations":[{"facility":"The Second Affiliated Hospital of Anhui University of Chinese Medicine","city":"Hefei","state":"Anhui","zip":"230031","country":"China","geoPoint":{"lat":31.86389,"lon":117.28083}}]},"ipdSharingStatementModule":{"ipdSharing":"NO","description":"At present, we have not made a decision on whether to share all IPD. This is because we need to consider a range of factors, including ethical principles, legal requirements, privacy protection, and data sharing agreements. We are carefully evaluating these factors and will make a clear decision as soon as possible."}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000003704","term":"Dementia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000019965","term":"Neurocognitive Disorders"},{"id":"D000001523","term":"Mental Disorders"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M6594","name":"Dementia","asFound":"Dementia","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21526","name":"Neurocognitive Disorders","relevance":"LOW"},{"id":"M4505","name":"Mental Disorders","relevance":"LOW"},{"id":"M14163","name":"Psychotic Disorders","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BXM","name":"Behaviors and Mental Disorders"}]},"interventionBrowseModule":{"meshes":[{"id":"D000009553","term":"Nimodipine"}],"ancestors":[{"id":"D000000959","term":"Antihypertensive Agents"},{"id":"D000002121","term":"Calcium Channel Blockers"},{"id":"D000049990","term":"Membrane Transport Modulators"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000077264","term":"Calcium-Regulating Hormones and Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000014665","term":"Vasodilator Agents"}],"browseLeaves":[{"id":"M12182","name":"Nimodipine","asFound":"Autoinjector","relevance":"HIGH"},{"id":"M3967","name":"Antihypertensive Agents","relevance":"LOW"},{"id":"M5071","name":"Calcium","relevance":"LOW"},{"id":"M5088","name":"Calcium, Dietary","relevance":"LOW"},{"id":"M5074","name":"Calcium Channel Blockers","relevance":"LOW"},{"id":"M9479","name":"Hormones","relevance":"LOW"},{"id":"M17102","name":"Vasodilator Agents","relevance":"LOW"}],"browseBranches":[{"abbrev":"AnAg","name":"Antihypertensive Agents"},{"abbrev":"ChanBlk","name":"Channel Blockers"},{"abbrev":"VaDiAg","name":"Vasodilator Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"BDCA","name":"Bone Density Conservation Agents"}]}},"hasResults":false}